UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microplastics: an often-overlooked issue in the transition from chronic inflammation to cancer

Journal of translational medicine, 2024-10, Vol.22 (1), p.959-11, Article 959

2024

Volltextzugriff (PDF)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis

Frontiers in oncology, 2020-06, Vol.10, p.904-904

2020

Volltextzugriff (PDF)

Association between magnesium depletion score and the risk of metabolic dysfunction associated steatotic liver disease: a cross sectional study

Scientific reports, 2024-10, Vol.14 (1), p.24627-11, Article 24627

2024

Volltextzugriff (PDF)

Exposure to air pollution, genetic susceptibility, and prevalence of sarcopenia in the UK

Ecotoxicology and environmental safety, 2024-10, Vol.285, p.117143, Article 117143

2024

Volltextzugriff (PDF)

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients

Frontiers in oncology, 2022-05, Vol.12, p.858712-858712

2022

Volltextzugriff (PDF)

Mental health problems among healthcare professionals following the workplace violence issue-mediating effect of risk perception

Frontiers in psychology, 2022-08, Vol.13, p.971102

2022

Volltextzugriff (PDF)

Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?

Journal of translational medicine, 2018-05, Vol.16 (1), p.122-122, Article 122

2018

Volltextzugriff (PDF)

Author Correction: Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

Genome Biology, 2021-09, Vol.22 (1), p.1-272, Article 272

2021

Volltextzugriff (PDF)

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”

Journal of Immunology Research, 2022-07, Vol.2022, p.1-2

2022

Volltextzugriff (PDF)

Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway

Oncotarget, 2017-06, Vol.8 (26), p.41975-41987

2017

Volltextzugriff (PDF)

Comprehensive analysis of immune indicators provides prognostic markers for early stage non-small cell lung cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14276-e14276

2019

Volltextzugriff (PDF)

644 A phase 1 dose escalation study of GCC19CART – A novel CoupledCAR® therapy for subjects with metastatic colorectal cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A737-A737

2023

Volltextzugriff (PDF)

Expert consensus on treatment for stage III non‐small cell lung cancer

Medicine advances (Online), 2023-03, Vol.1 (1), p.3-13

2023

Volltextzugriff (PDF)

FLI1 circular RNA as biomarkers for tracking disease progression and as potential therapeutic targets in small cell lung cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20573-e20573

2018

Volltextzugriff (PDF)

Exploring the association between lifestyle and cardiovascular health metrics and HPV infection risk: insights from the National Health and Nutrition Examination Survey 2005-2016 data

BMC public health, 2024-10, Vol.24 (1), p.3028

2024

Volltextzugriff (PDF)

A multicenter real-world study on the efficacy and safety of anlotinib-based treatment for metastatic breast cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13120-e13120

2024

Volltextzugriff (PDF)

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations

Journal of clinical oncology, 2022-09, Vol.40 (27), p.JCO2102641-3171

2022

Volltextzugriff (PDF)

Effect of MALAT1 in the crosstalk between nucleus and mitochondria on mitochondrial reprogramming in hepatocellular carcinoma cells

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14711-e14711

2019

Volltextzugriff (PDF)

Cost-effectiveness of PD-L1 testing and tumor mutational burden testing of immune checkpoint inhibitors for non-small cell lung cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20689-e20689

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive small cell lung cancer in China

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20083-e20083

2019

Volltextzugriff (PDF)

The application of immunonutrition in patients with cancer: current status and future perspectives

Holistic Integrative Oncology, 2024-09, Vol.3 (1), p.45, Article 45

2024

Volltextzugriff (PDF)

Efficacy and safety of IBI110 in combination with sintilimab in first-line advanced HER2-negative gastric cancer or gastroesophageal junction cancer: Preliminary results from a phase Ib study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16097-e16097

2022

Volltextzugriff (PDF)

Abstract CT035: Safety/tolerability and preliminary antitumor activity of sitravatinib plus tislelizumab in patients with PD-(L)1 refractory/resistant unresectable or metastatic melanoma from a phase 1b study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT035-CT035

2021

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(131)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Microplastics: an often-overlooked issue in the transition from chronic inflammation to cancer

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis

Association between magnesium depletion score and the risk of metabolic dysfunction associated steatotic liver disease: a cross sectional study

Exposure to air pollution, genetic susceptibility, and prevalence of sarcopenia in the UK

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients

Mental health problems among healthcare professionals following the workplace violence issue-mediating effect of risk perception

Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?

Author Correction: Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”

Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway

Comprehensive analysis of immune indicators provides prognostic markers for early stage non-small cell lung cancer

644 A phase 1 dose escalation study of GCC19CART – A novel CoupledCAR® therapy for subjects with metastatic colorectal cancer

Expert consensus on treatment for stage III non‐small cell lung cancer

FLI1 circular RNA as biomarkers for tracking disease progression and as potential therapeutic targets in small cell lung cancer

Exploring the association between lifestyle and cardiovascular health metrics and HPV infection risk: insights from the National Health and Nutrition Examination Survey 2005-2016 data

A multicenter real-world study on the efficacy and safety of anlotinib-based treatment for metastatic breast cancer

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations

Effect of MALAT1 in the crosstalk between nucleus and mitochondria on mitochondrial reprogramming in hepatocellular carcinoma cells

Cost-effectiveness of PD-L1 testing and tumor mutational burden testing of immune checkpoint inhibitors for non-small cell lung cancer

Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive small cell lung cancer in China

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

The application of immunonutrition in patients with cancer: current status and future perspectives

Efficacy and safety of IBI110 in combination with sintilimab in first-line advanced HER2-negative gastric cancer or gastroesophageal junction cancer: Preliminary results from a phase Ib study

Abstract CT035: Safety/tolerability and preliminary antitumor activity of sitravatinib plus tislelizumab in patients with PD-(L)1 refractory/resistant unresectable or metastatic melanoma from a phase 1b study

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

Aktive Filter

Suchergebnisse filtern